You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

Details for Patent: 4,885,100


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,885,100
Title: Tris(isonitrile)copper(I) adducts for preparing radionuclide complexes
Abstract:Tris(isonitrile)copper(I) complex salts with anions selected from BF.sub.4, PF.sub.6, ClO.sub.4, I, Br, Cl and CF.sub.3 COO are useful in preparing radionuclide complexes rapidly at room temperature. Preferred isonitrile ligands are ether isonitriles. The tris(isonitrile)copper(I) adducts enable technetium complexes, such as those of Tc99m, to be prepared easily just prior to their use as imaging agents.
Inventor(s): Iqbal; Tahir (Lowell, MA), Cain, Jr.; John H. (Merrimack, NH), Slosky; Jack J. (Shrewsbury, MA)
Assignee: E. I. Du Pont de Nemours and Company (Wilmington, DE)
Application Number:07/095,924
Patent Claim Types:
see list of patent claims
Compound; Device;

Drugs Protected by US Patent 4,885,100

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,885,100

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 117306 ⤷  Try a Trial
Germany 3852828 ⤷  Try a Trial
European Patent Office 0395695 ⤷  Try a Trial
Japan H03501255 ⤷  Try a Trial
Japan H0653750 ⤷  Try a Trial
Mexico 9203600 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 8902433 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.